Literature DB >> 6239679

Lysosomal enzymes in ataxia: discovery of two new cases of late onset hexosaminidase A and B deficiency (adult Sandhoff disease) in French Canadians.

A Barbeau, L Plasse, T Cloutier, S Paris, M Roy.   

Abstract

We have measured in leukocytes the following lysosomal enzymes in 11 Friedreich disease cases, 11 "atypical" recessive ataxias, 13 neurological controls and 16 normal controls: hexosaminidase A and B; beta-galactosidase and neuraminidase (labile and cold stable, or A and B). The lysosomal enzyme deficiencies known to produce certain forms of spinocerebellar degeneration were not present in Friedreich's disease or the Charlevoix-Saguenay syndrome. The very small scale survey of "atypical" recessive ataxias revealed 3 cases of severe deficiencies in hexosaminidase activity. Two adult brothers presenting with the clinical phenotype of Kugelberg-Welander disease (one also with ataxia), were shown to have a severe deficiency of both HEX A and HEX B activity (Sandhoff biochemical pattern). This is the first such report. A further adult female patient, unrelated to the others, had a severe isolated deficiency of HEX B and presented with a very slowly progressive and mild ataxia with severe internal strabismus. These patients and their families are being studied clinically and biochemically in greater detail and will be reported elsewhere. However these preliminary findings justify screening for such lysosomal defects in all cases of "atypical" recessive ataxia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239679     DOI: 10.1017/s0317167100035125

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  6 in total

1.  Neurophysiological study in chronic GM2 gangliosidosis (hexosaminidase A and B deficiency), with motor neuron disease phenotype.

Authors:  M Mondelli; A Rossi; S Palmeri; N Rizzuto; A Federico
Journal:  Ital J Neurol Sci       Date:  1989-08

2.  A common beta hexosaminidase gene mutation in adult Sandhoff disease patients.

Authors:  M Gomez-Lira; A Sangalli; M Mottes; C Perusi; P F Pignatti; N Rizzuto; A Salviati
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

3.  Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.

Authors:  K Neote; B McInnes; D J Mahuran; R A Gravel
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Early and severe sensory loss in three adult siblings with hexosaminidase A and B deficiency (Sandhoff disease).

Authors:  H Schnorf; R Gitzelmann; N U Bosshard; M Spycher; W Waespe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

5.  Sandhoff disease mimicking adult-onset bulbospinal neuronopathy.

Authors:  P K Thomas; E Young; R H King
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

6.  GM2-Gangliosidosis (Sandhoff and Tay Sachs disease): Diagnosis and Neuroimaging Findings (An Iranian Pediatric Case Series).

Authors:  Parvaneh Karimzadeh; Narjes Jafari; Habibeh Nejad Biglari; Sayena Jabbeh Dari; Farzad Ahmad Abadi; Mohammad-Reza Alaee; Hamid Nemati; Sasan Saket; Seyed Hasan Tonekaboni; Mohammad-Mahdi Taghdiri; Mohammad Ghofrani
Journal:  Iran J Child Neurol       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.